Posted by Michael Wonder on 08 Jun 2021
Moderna files for conditional marketing approval for its COVID-19 vaccine in adolescents in the European Union
7 June 2021 - Submission based on Phase 2/3 study of mRNA-1273 in adolescents ages 12 to less than 18 in the U.S.
Moderna, today announced that it has submitted for a conditional marketing approval for its COVID-19 vaccine in adolescents with the EMA.
